S. Çelik And L. Kaynar, "Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis," Journal of Current Hematology & Oncology Research , vol.2, no.1, pp.20-21, 2024
Çelik, S. And Kaynar, L. 2024. Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis. Journal of Current Hematology & Oncology Research , vol.2, no.1 , 20-21.
Çelik, S., & Kaynar, L., (2024). Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis. Journal of Current Hematology & Oncology Research , vol.2, no.1, 20-21.
Çelik, Serhat, And Leylagül KAYNAR. "Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis," Journal of Current Hematology & Oncology Research , vol.2, no.1, 20-21, 2024
Çelik, Serhat And Kaynar, Leylagül. "Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis." Journal of Current Hematology & Oncology Research , vol.2, no.1, pp.20-21, 2024
Çelik, S. And Kaynar, L. (2024) . "Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis." Journal of Current Hematology & Oncology Research , vol.2, no.1, pp.20-21.
@article{article, author={Serhat Çelik And author={Leylagül KAYNAR}, title={Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis}, journal={Journal of Current Hematology & Oncology Research}, year=2024, pages={20-21} }